Tuesday - March 10, 2026

Ulcerative Colitis Treatment Pipeline Shows Strong Momentum as 70+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Ulcerative Colitis Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in the Ulcerative Colitis Pipeline Landscape. It covers the Ulcerative Colitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading

Type 1 Diabetes Clinical Trial Pipeline Shows Potential with Active Contributions from 85+ Key Companies | DelveInsight

DelveInsight’s, “Type 1 Diabetes Pipeline Insight, 2026” report provides comprehensive insights about 85+ companies and 100+ pipeline drugs in Type 1 Diabetes pipeline landscape. It covers the Type 1 Diabetes pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading

TCR Therapy Clinical Trial Pipeline Accelerates as 50+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “TCR Therapy Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the TCR Therapy pipeline landscape. It covers the TCR Therapy pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading

Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum: 120+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Systemic Lupus Erythematosus Pipeline Insights 2026” report provides comprehensive insights about 120+ companies and 140+ pipeline drugs in Systemic Lupus Erythematosus pipeline landscape. It covers the Systemic Lupus Erythematosus pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading

Former Ontario Ministry of Health Chief Architect Hugo Raposo Discusses How AI Is Transforming Canada’s Healthcare Systems

Artificial intelligence is becoming the digital foundation of modern healthcare systems. By connecting data, clinicians, and intelligent platforms, we can transform how care is delivered and improve health outcomes across entire populations. Artificial intelligence is redefining the future of healthcare … Continue reading

Type 2 Diabetes Clinical Trial Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Type 2 Diabetes Pipeline Insight, 2026” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Type 2 Diabetes pipeline landscape. It covers the Type 2 Diabetes pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading

Hematology Analyzers and Reagents Market Projected to Reach $8.8 Billion by 2029 Driven by Rising Blood Testing Demand

Hematology Analyzers and Reagents Market by Product (Instrument (PoC, Semi-automated), Reagent, Consumable, Service), Price (High, Mid, Low), Application (Anemia, Blood Cancer), End User (Hospital, CTL, Govt Lab, Blood Bank) – Global Forecast to 2029 According to MarketsandMarkets™, The report “Hematology … Continue reading

Global Ultrasound Market Projected to Reach $13.87 Billion by 2030 Driven by Advancements in Diagnostic Imaging

Ultrasound Market by Technology (2D,3D,Doppler,CEU,HIFU, ESWL), Display (Colour, B/W), Portability (Trolly, Compact,POC), Component (Linear, Phased array, Workstation), Application (OB/GYN, Cardiology, Ortho), End User (Hospitals) Global Forecasts to 2030 According to MarketsandMarkets™, The report “Ultrasound Market by Technology (2D,3D,Doppler,CEU,HIFU, ESWL), Display … Continue reading

Pharmaceutical Drug Delivery Market Projected to Reach $2,546.0 Billion by 2029 with Advancements in Targeted Therapies

Pharmaceutical Drug Delivery Market by Route of Administration [Oral, Injectors (Pen, Auto Injectors) Implantable, Syrups, Gels, Pulmonary, Tablets, Syringes], Application (Cancer, Diabetes), Facility of Use (Hospital, Home Care) -Global Forecast to 2029 According to MarketsandMarkets™, The report “Pharmaceutical Drug Delivery … Continue reading

Veterinary Diagnostics Market to Reach $5.36 Billion by 2030 Driven by Rising Animal Health Awareness

Veterinary Diagnostics Market by Technology (PCR, ELISA, Lateral Flow Assay, Molecular Diagnostics, Immunodiagnostics), Product (Consumables, Instruments), Animal (Companion, Livestock, Swine), Application (Infectious, Bacteria) – Global Forecast to 2030 According to MarketsandMarkets™, The report “Veterinary Diagnostic Market by Technology (PCR, ELISA, … Continue reading